Inquiry Basket
Services Details
In 2020, the global outbreak of CovID-19 caused a large amount of investment and research activities to develop vaccines. Many organizations are using published genomes to develop possible anti-SARS-CoV-2 vaccines. An mRNA vaccine against SARS-CoV-2, the causative virus, may show its advantages in a shorter time and become a valuable tool for disease prevention.
BOC Sicences' mRNA Vaccine Development Services
Relying on advanced mRNA technology and rich experience in the development of mRNA vaccines, BOC RNA can design and synthesize mRNA sequences from DNA templates and produce laboratory-scale or GMP-level mRNA vaccines to match your application from research to clinical trials.
Why develop COVID-19 mRNA Vaccine?
- When the mRNA vaccine enters the cell, it can produce a protein similar to the viral antigen, thereby activating the immune response and producing antibodies that can specifically bind the protein and the real viral antigen.
- Compared with the traditional vaccine research and development process, the mRNA program reduces the recombinant protein production process and enables faster discovery and development into the clinic.
- Through computer program design, antigens can be quickly generated and tested in clinical models, thereby speeding up vaccine screening.
Since the emergence of the new coronavirus (COVID-19), BOC RNA has stepped up our efforts and is committed to research and development of vaccines and treatments to contain the virus. We will continue to maintain industry cooperation to achieve the greatest chance of success.
More Information
Other COVID-19 Related Services
Liposomes Drug Delivery Services For COVID-19
Custom Oligo Synthesis Services For COVID-19 Research
COVID-19 Resources & News
| ||
Will the mRNA vaccine become the “savior” of COVID-19？ Cell Immunity: SARS-CoV-2 vaccines status bioRxiv.: Scientists Find siRNA drugs that may inhibit SARS-CoV-2 | ||
* Only for research. Not suitable for any diagnostic or therapeutic use.
Online Inquiry
Services
Products
Highlighted Services
GMP Oligonucleotide Manufacturing Service
For more than 15 years, BOC Sciences has been manufacturing oligonucleotides for pre-clinical, pharmaceutical, food safety, and animal health industries. We provide customized and flexible oligonucleotide GMP or non-GMP production services to meet different production needs.
Lipid Nanoparticle(LNP) for RNA Delivery
BOC Sciences offers comprehensive LNP- mRNA delivery services tailored to meet the specific needs of mRNA vaccine development. Our expertise in nanoparticle formulation and mRNA chemistry enables us to design custom LNP formulations optimized for stability, efficacy, and safety.
BOC Sciences promises to offer you with GalNAc-siRNA conjugation services to help you conduct further research on GalNAc-siRNA conjugates and explore their mores omnics capabilities, the working mechanism as well as their potential therapeutic profiles.
BOC Sciences offers aptamer customization services to generate high-quality aptamers tailored to your goals, delivering excellent results even for the most difficult target molecules.
Peptide-Oligonucleotide Conjugation
BOC Sciences is committed to providing our customers with comprehensive modification and labeling, offering affordable custom oligonucleotides or peptide-oligonucleotide conjugates.
